We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
BIOKE and Fluidigm Announce Exclusive Distribution Agreement
News

BIOKE and Fluidigm Announce Exclusive Distribution Agreement

BIOKE and Fluidigm Announce Exclusive Distribution Agreement
News

BIOKE and Fluidigm Announce Exclusive Distribution Agreement

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "BIOKE and Fluidigm Announce Exclusive Distribution Agreement"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Fluidigm Corporation and BIOKE have announced an agreement in which BIOKE is appointed as exclusive distributor for the BioMark™ System for real-time PCR and genotyping in the Benelux.

The Fluidigm says that the BioMark system provides orders-of-magnitude increase in throughput compared to conventional RT-PCR and genotyping platforms, at a fraction of the labor and running cost. This breakthrough is possible because the BioMark system reads dynamic arrays – nanofluidic chips that contain preprogrammed fluidic networks that automatically combine sets of samples with sets of PCR assays.

BioMark dynamic arrays can provide a high-throughput and means to validate gene- or SNP-based biomarkers by PCR. An array generates 2,304 PCR assays, yet it requires only 96 pipetting steps (input of 48 off-the-shelf primer-probe sets and 48 samples), or 1/40 the pipetting steps required by 384-well systems.

Advertisement